Back to top

Why You Shouldn't Bet Against Hanwha Q CELLS (HQCL) Stock

Read MoreHide Full Article

One stock that might be an intriguing choice for investors right now is Hanwha Q CELLS Co., Ltd. (HQCL - Free Report) . This is because this security in the Solar space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Solar space as it currently has a Zacks Industry Rank of 31 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Hanwha Q CELLS is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

Hanwha Q CELLS Co., Ltd. Price and Consensus

In fact, over the past month, current quarter estimates have risen from 9 cents per share to 11 cents per share, while current year estimates have risen from 38 cents per share to 56 cents per share. The company currently carries a Zacks Rank #3 (Hold), which is also a favorable signal.  You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a decent pick in a strong industry, consider Hanwha Q CELLS. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Hanwha Q CELLS Co., Ltd. (HQCL) - free report >>

More from Zacks Tale of the Tape

You May Like